{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:34:03Z","timestamp":1790728443209,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18fk0108050"],"award-info":[{"award-number":["JP18fk0108050"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["JPMJCR1413"],"award-info":[{"award-number":["JPMJCR1413"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16KT0130 and 17H04701"],"award-info":[{"award-number":["16KT0130 and 17H04701"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009427","name":"Telecommunications Advancement Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100009427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-6804-3","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T12:06:26Z","timestamp":1556021186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study"],"prefix":"10.1186","volume":"19","author":[{"given":"Fumitaka","family":"Terahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0941-8537","authenticated-orcid":false,"given":"Hiroshi","family":"Nishiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"key":"6804_CR1","volume-title":"Antimicrobial resistance. Global action plan on antimicrobial resistance","author":"World Health Organization (WHO)","year":"2015","unstructured":"World Health Organization (WHO). Antimicrobial resistance. Global action plan on antimicrobial resistance. Geneva: WHO; 2015. Available from: \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/193736\/9789241509763_eng.pdf"},{"key":"6804_CR2","unstructured":"The Government of Japan. National action plan on antimicrobial resistance (AMR) 2016\u20132020. Available from: \n                    https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10900000-Kenkoukyoku\/0000138942.pdf"},{"key":"6804_CR3","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.3390\/ijerph10126235","volume":"10","author":"N Allocati","year":"2013","unstructured":"Allocati N, Masulli M, Alexeyev MF, et al. Escherichia coli in Europe: an overview. Int J Environ Res Public Health. 2013;10:6235\u201354.","journal-title":"Int J Environ Res Public Health"},{"key":"6804_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, et al. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.","journal-title":"BMC Infect Dis"},{"key":"6804_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176\u201387.","journal-title":"Lancet."},{"key":"6804_CR6","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1093\/jac\/dku283","volume":"69","author":"V De Lastours","year":"2014","unstructured":"De Lastours V, Chau F, Roy C, et al. Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone. J Antimicrob Chemother. 2014;69:3393\u2013400.","journal-title":"J Antimicrob Chemother"},{"key":"6804_CR7","first-page":"10","volume":"28","author":"CR Kiffer","year":"2011","unstructured":"Kiffer CR, Camargo EC, Shimakura SE, et al. A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil. Int J Health Geogr. 2011;28:10\u20137.","journal-title":"Int J Health Geogr"},{"key":"6804_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/jac\/dkq471","volume":"66","author":"O Cuevas","year":"2011","unstructured":"Cuevas O, Oteo J, L\u00e1zaro E, et al. Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin\/clavulanic acid. J Antimicrob Chemother. 2011;66:664\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"6804_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1128\/AAC.01076-09","volume":"54","author":"LY Hsu","year":"2010","unstructured":"Hsu LY, Tan TY, Tam VH, et al. Surveillance and correlation of antibiotic prescription and resistance of gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother. 2010;54:1173\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"6804_CR10","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1093\/jac\/dkq351","volume":"65","author":"A Gallini","year":"2010","unstructured":"Gallini A, Degris E, Desplas M, et al. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. J Antimicrob Chemother. 2010;65:2650\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"6804_CR11","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/jac\/dkq093","volume":"65","author":"US Jensen","year":"2010","unstructured":"Jensen US, Muller A, Brandt CT, et al. Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance. J Antimicrob Chemother. 2010;65:1286\u201391.","journal-title":"J Antimicrob Chemother"},{"key":"6804_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s15010-007-7083-y","volume":"36","author":"R Colodner","year":"2008","unstructured":"Colodner R, Kometiani I, Chazan B, et al. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection. 2008;36:41\u20135.","journal-title":"Infection."},{"key":"6804_CR13","first-page":"423","volume":"30","author":"M Zemkova","year":"2007","unstructured":"Zemkova M, Kotlarova J, Merka V, et al. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology. New Microbiol. 2007;30:423\u201330.","journal-title":"New Microbiol"},{"key":"6804_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1469-0691.2005.01098.x","volume":"11","author":"A Mahamat","year":"2005","unstructured":"Mahamat A, Lavigne JP, Fabbro-Peray P, et al. Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a French university hospital: application of the dynamic regression model. Clin Microbiol Infect. 2005;11:301\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"6804_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jac\/dkh510","volume":"55","author":"WV Kern","year":"2005","unstructured":"Kern WV, Steib-Bauert M, de With K, et al. Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999\u20132002. J Antimicrob Chemother. 2005;55:57\u201360.","journal-title":"J Antimicrob Chemother"},{"key":"6804_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/pds.1110","volume":"14","author":"K Urb\u00e1nek","year":"2005","unstructured":"Urb\u00e1nek K, Kol\u00e1r M, Strojil J, et al. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Pharmacoepidemiol Drug Saf. 2005;14:741\u20135.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6804_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ijantimicag.2005.08.016","volume":"26","author":"PR Hsueh","year":"2005","unstructured":"Hsueh PR, Chen WH, Luh KT, et al. Relationships between antimicrobial use and antimicrobial resistance in gram-negative bacteria causing nosocomial infections from 1991\u20132003 at a university hospital in Taiwan. Int J Antimicrob Agents. 2005;26:463\u201372.","journal-title":"Int J Antimicrob Agents"},{"key":"6804_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.eururo.2015.05.010","volume":"69","author":"T Cai","year":"2016","unstructured":"Cai T, Verze P, Brugnolli A, et al. Adherence to European Association of Urology guidelines on prophylactic antibiotics: an important step in antimicrobial stewardship. Eur Urol. 2016;69:276\u201383.","journal-title":"Eur Urol"},{"key":"6804_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/1471-2334-14-393","volume":"14","author":"PH Wong","year":"2014","unstructured":"Wong PH, von Krosigk M, Roscoe DL, et al. Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002\u20132011. BMC Infect Dis. 2014;14:393.","journal-title":"BMC Infect Dis"},{"key":"6804_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1086\/605530","volume":"49","author":"BS Gottesman","year":"2009","unstructured":"Gottesman BS, Carmeli Y, Shitrit P, et al. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis. 2009;49:869\u201375.","journal-title":"Clin Infect Dis"},{"key":"6804_CR21","unstructured":"Japanese Ministry of Health, Labour and Welfare. Japan Nosocomial Infections Surveillance (JANIS). Annual open report by prefecture 2015 and 2016. Available from: \n                    https:\/\/janis.mhlw.go.jp\/report\/kensa_prefectures.html"},{"key":"6804_CR22","unstructured":"The AMR Clinical Reference Centre of National Centre for Global Health and Medicine. Antimicrobial consumption surveillance. Available from: \n                    http:\/\/amrcrc.ncgm.go.jp\/surveillance\/index.html"},{"key":"6804_CR23","unstructured":"World Health Organization (WHO) Collaborating Centre for Drug Statistics and Methodology. ATC\/DDD Index 2018. Available from: \n                    https:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"6804_CR24","unstructured":"Japanese Ministry of Health, Labour and Welfare. Survey of Physicians, Dentists and Pharmacists 2016. Available from: https:\/\/www.mhlw.go.jp\/english\/database\/db-hss\/dl\/spdp_2016.pdf (details in Japanese)."},{"key":"6804_CR25","unstructured":"Japanese Ministry of Health, Labour and Welfare. Report on Public Health Administration and Services 2015 and 2016. Available from: \n                    https:\/\/www.mhlw.go.jp\/english\/database\/db-hss\/dl\/rophas_2016_year.pdf\n                    \n                   (details in Japanese)."},{"key":"6804_CR26","unstructured":"Japanese Ministry of Health, Labour and Welfare. Summary of static\/dynamic survey of medical institutions and hospital report 2014. Dynamic survey in 2015 and 2016. Available from: \n                    https:\/\/www.mhlw.go.jp\/english\/database\/db-hss\/mih_report_2014.html\n                    \n                   (details in Japanese)."},{"key":"6804_CR27","unstructured":"Japanese Ministry of Health, Labour and Welfare. Results of \u201csurvey of institutions and establishments for long-term care\u201d for 2016. The number of nursing homes per 100,000 people in 2015 and 2016. Available from: \n                    https:\/\/www.mhlw.go.jp\/english\/database\/db-hss\/dl\/siel-2016-02.pdf\n                    \n                   (details in Japanese)."},{"key":"6804_CR28","unstructured":"Japanese Cabinet Office. Annual Report on the Aging Society: 2017. 2015 aging rate (%). Available from: \n                    http:\/\/www8.cao.go.jp\/kourei\/english\/annualreport\/2017\/pdf\/c1-1.pdf"},{"key":"6804_CR29","unstructured":"Japanese Ministry of Health, Labour and Welfare. Results of \u201csurvey of institutions and establishments for long-term care\u201d for 2016. Average lengths of hospitalization days in 2015 and 2016. Available from: \n                    https:\/\/www.mhlw.go.jp\/english\/database\/db-hss\/dl\/siel-2016-02.pdf\n                    \n                   (details in Japanese)."},{"key":"6804_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s15010-017-1097-x","volume":"46","author":"D Yamasaki","year":"2018","unstructured":"Yamasaki D, Tanabe M, Muraki Y, et al. The first report of Japanese antimicrobial use measured by National Database Based on health insurance claims data (2011\u20132013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group. Infection. 2018;46:207\u201314.","journal-title":"Infection."},{"key":"6804_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/jac\/dkt422","volume":"69","author":"V De Lastours","year":"2013","unstructured":"De Lastours V, Bleibtreu A, Chau F, et al. Quinolone-resistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle. J Antimicrob Chemother. 2013;69:761\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"6804_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000361011","volume":"59","author":"N Tsukamoto","year":"2013","unstructured":"Tsukamoto N, Ohkoshi Y, Okubo T, et al. High prevalence of cross-resistance to aminoglycosides in fluoroquinolone-resistant Escherichia coli clinical isolates. Chemotherapy. 2013;59:379\u201384.","journal-title":"Chemotherapy."},{"key":"6804_CR33","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/infdis\/jis567","volume":"206","author":"JH Han","year":"2012","unstructured":"Han JH, Nachamkin I, Tolomeo P, et al. Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli. J Infect Dis. 2012;206:1597\u2013603.","journal-title":"J Infect Dis"},{"key":"6804_CR34","unstructured":"Japanese Ministry of Health, Labour and Welfare. Healthcare insurance database. Analysis of different regions. Available from: \n                    https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-12400000-Hokenkyoku\/0000095909.pdf\n                    \n                   (in Japanese)."},{"key":"6804_CR35","doi-asserted-by":"publisher","unstructured":"Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017:CD003543. \n                    https:\/\/doi.org\/10.1002\/14651858.CD003543.pub4\n                    \n                  .","DOI":"10.1002\/14651858.CD003543.pub4"},{"key":"6804_CR36","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1093\/cid\/cix017","volume":"64","author":"H Honda","year":"2017","unstructured":"Honda H, Ohmagari N, Tokuda Y, et al. Antimicrobial stewardship in inpatient settings in the Asia Pacific region: a systematic review and meta-analysis. Clin Infect Dis. 2017;64:S119\u201326.","journal-title":"Clin Infect Dis"},{"key":"6804_CR37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","volume":"16","author":"EC Schuts","year":"2016","unstructured":"Schuts EC, Hulscher ME, Mouton JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:847\u201356.","journal-title":"Lancet Infect Dis"},{"key":"6804_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1017\/ice.2014.41","volume":"36","author":"DM Drekonja","year":"2015","unstructured":"Drekonja DM, Filice GA, Greer N, et al. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol. 2015;36:142\u201352.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6804_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159\u201377.","journal-title":"Clin Infect Dis"},{"key":"6804_CR40","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62:e51\u201377.","journal-title":"Clin Infect Dis"},{"key":"6804_CR41","unstructured":"Ministry of Health, Labour and Welfare, Japan. Ethics rules for clinical studies. Tokyo: Ministry of Health, Labour and Welfare, 2009. Available from: \n                    https:\/\/www.mhlw.go.jp\/general\/seido\/kousei\/i-kenkyu\/rinsyo\/dl\/gigisyoukai.pdf"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6804-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-6804-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6804-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T09:07:06Z","timestamp":1589447226000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-6804-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6804"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-6804-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"23 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors are experts with interest in Infectious Disease Epidemiology and also in Theoretical Epidemiology, and the corresponding author acts as the chairperson and team leader of the Department of Hygiene, Hokkaido University Graduate School of Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The present study analyzed data that is publicly available. As such, the datasets used in our study were de-identified and fully anonymized in advance, and the analysis of publicly available data without identity information does not require ethical approval [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"426"}}